Venue: XXII EAACI Paris Congress
Date: 9 June 2003, PARIS, FRANCE
The Chairman of the IT IG, Dr Emilio Alvarez Cuesta ( EAC ) called the meeting to order at 17.30, welcomed the participants and chaired the meeting.
The Secretary of the EAACI IT IG, Dr Erkka Valovirta ( EV ) acted as the Secretary.
12 members of the IT IG attended. The number of the members of EAACI IT IG is in total 1814 (5.7.2003).
b.Educational Programme Task Force ( TF ): EAC informed that EAMG, the European Allergen Manufacturers Group has decided to sponsor the Educational Programme TF.
- a.Website : It was decided that EV is the Webmaster of EAACI IT IG and DC is the Techical Assistant. EV contacts the publisher of Munksgaard in order to ask the possibilities to have on the Website the EAACI Position Paper on Immunotherapy and Hymenoptera Immunotherapy, published in Allergy in 1993. The appendixes contain practical information and forms to be used during IT, so they could be downloaded from the Website. EV reported that several requests about this possibility have come from the members. In addition to this the WHO Position Paper published in Allergy in 1998 should be in the Website, EV to ask also this. EV contacts also the ARIA Group/ prof Jean Bousquet so that there is a link from EAACI IT IG Website to the ARIA Website.
b. Educational Programme Task Force: EAMG sponsors this TF. It was decided that EAC contacts the members of the TF ( Steering Committee :EAC, Jean Bousquet, Hans-Jorgen Malling, EV, Stephen Durham, Walter Canonica and a representative from Poland, the name to be announced later; Scientific Reference Group : Steering Committee members and Giovanni Passalaqua and Ulrich Muller; and Clinical Reference Group : Steering Committee Members and David Price, Kristof Nekam, Sabina Rak, Susanne Lau, Mariedelaide Franchi, Samatha Walker and Ulrich Muller) so that the group can start to work.
c. European Immunotherapy Fatalities Survey: It was decided that AB contacts once more those societies who did not response (n=28). It is the purpose in the future that the systemic reactions could be reported in the EAACI IT IG Website. It is also the purpose that the results of the Fatalities Survey should be published in scientific allergological journal. AB and EAC continue to work.
d. Relationship with the EAACI Newsletter: It was decided that the Secretary of EAACI IT IG continues to be the contact person also in the future. Editor in Chief is prof Claus Bachert.
f. Other Action Items to be dicussed: no other items raised.
VI. Any other business: no other business raised.
VII. Closure of the EAACI IT IG ABM by EAC at 18.25